Health Condition 1: PCS-
Conditions
Interventions
Intervention1: Group â?? D:
To Receive infusion dexmedetomidine @ 1mcg/kg/hr post induction: intra-operatively patient will Receive infusion dexmedetomidine @ 1mcg/kg/hr post induction
Intervention2:
Sponsors
AIIMS RISHIKESH
Eligibility
Inclusion criteria
Inclusion criteria: 2. ASA â??I, II 3. Fasting glucose 4. Patients undergoing surgery under general anaesthesia 5. Surgery duration > 1hr and
Exclusion criteria
Exclusion criteria: 1. BMI > 35 kg/m2 2. Severe cardiac, pulmonary, renal, hepatic dysfunction or any metabolic disorders 3. Pregnant patient 4. Allergy to dexmedetomidine 5. Patient receiving medications which affect sympathetic response or hormonal secretions 6. Patient refusal to participate 7. Emergency surgery 8. Complicated surgeries of more than 2.5h
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare post- operative blood glucose level at 1hr (from the point of stopping of infusion) with pre operative blood glucose valueTimepoint: Compare post- operative blood glucose level at 1hr (from the point of stopping of infusion) with pre operative blood glucose value | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To monitor blood glucose level 3rd hr, 6th hr post operatively 2. To monitor blood glucose level 30 minute post induction 3. To note an side effects like bradycardia(HR 50/min), hypotension (MAP 20% of baseline BP) /hypertension ( MAP 20% of baseline BP) , hypoglycaemia ( RBS 70mg/dl) /hyperglycemia( RBS 200mg/dl) requiring intervension Timepoint: To monitor blood glucose level 3rd hr, 6th hr post operatively | — |
Countries
India
Contacts
Public ContactDr Yashwant Singh Payal
AIIMS RISHIKESH
Outcome results
None listed